Sun protection education for adolescents: a feasibility study of a wait-list controlled trial of an intervention involving a presentation, action planning, and SMS messages and using objective measurement of sun exposure.
Adolescent
Feasibility Studies
Female
Health Behavior
Health Education
/ methods
Humans
Intention
Male
Melanoma
/ epidemiology
Risk Assessment
Self Report
Self-Examination
/ psychology
Skin Neoplasms
/ epidemiology
Students
/ psychology
Sunbathing
/ psychology
Sunburn
/ epidemiology
Sunlight
/ adverse effects
Text Messaging
United Kingdom
/ epidemiology
Waiting Lists
Adolescence
Skin cancer
Skin self-examination
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
30 Jan 2020
30 Jan 2020
Historique:
received:
12
06
2019
accepted:
22
01
2020
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
10
5
2020
Statut:
epublish
Résumé
People increase their risk of melanoma unless they are protected from the harmful effects of sun exposure during childhood and adolescence. We aimed to assess the feasibility of a three-component sun protection intervention- presentation, action planning, and SMS messages - and trial parameters. This feasibility wait-list trial was conducted in the United Kingdom in 2018. Students aged 13-15 years were eligible. Feasibility outcomes were collected for recruitment rates; data availability rates for objective measurements of melanin and erythema using a Mexameter and self-reported sunburn occurrences, severity and body location, tanning, sun protection behaviours and Skin Self-Examination (SSE) collected before (baseline) and after the school summer holidays (follow-up); intervention reach, adherence, perceived impact and acceptability. Quantitative data were analysed using descriptive statistics; qualitative data were analysed thematically. Five out of eight schools expressing an interest in participating with four allocated to act as intervention and one control. Four parents/carers opted their child out of the study. Four hundred and eighty-seven out of 724 students on the school register consented to the study at baseline (67%). Three hundred and eighty-five were in intervention group schools. Objective skin measurements were available for 255 (66%) of the intervention group at baseline and 237 (61%) of the group at follow up. Melanin increased; erythema decreased. Complete self-report data were available for 247 (64%) students in the intervention group. The number of students on the school register who attended the presentation and given the booklet was 379 (98%) and gave their mobile phone number was 155 (40%). No intervention component was perceived as more impactful on sun protection behaviours. Adolescents did not see the relevance of sun protection in the UK or for their age group. This is the first study to use a Mexameter to measure skin colour in adolescents. Erythema (visible redness) lasts no more than three days and its measurement before and after a six week summer holiday may not yield relevant or meaningful data. A major challenge is that adolescents do not see the relevance of sun protection and SSE. International Standard Randomised Controlled Trial Number ISRCTN11141528. Date registered 0/2/03/2018; last edited 31/05/2018. Retrospectively registered.
Sections du résumé
BACKGROUND
BACKGROUND
People increase their risk of melanoma unless they are protected from the harmful effects of sun exposure during childhood and adolescence. We aimed to assess the feasibility of a three-component sun protection intervention- presentation, action planning, and SMS messages - and trial parameters.
METHODS
METHODS
This feasibility wait-list trial was conducted in the United Kingdom in 2018. Students aged 13-15 years were eligible. Feasibility outcomes were collected for recruitment rates; data availability rates for objective measurements of melanin and erythema using a Mexameter and self-reported sunburn occurrences, severity and body location, tanning, sun protection behaviours and Skin Self-Examination (SSE) collected before (baseline) and after the school summer holidays (follow-up); intervention reach, adherence, perceived impact and acceptability. Quantitative data were analysed using descriptive statistics; qualitative data were analysed thematically.
RESULTS
RESULTS
Five out of eight schools expressing an interest in participating with four allocated to act as intervention and one control. Four parents/carers opted their child out of the study. Four hundred and eighty-seven out of 724 students on the school register consented to the study at baseline (67%). Three hundred and eighty-five were in intervention group schools. Objective skin measurements were available for 255 (66%) of the intervention group at baseline and 237 (61%) of the group at follow up. Melanin increased; erythema decreased. Complete self-report data were available for 247 (64%) students in the intervention group. The number of students on the school register who attended the presentation and given the booklet was 379 (98%) and gave their mobile phone number was 155 (40%). No intervention component was perceived as more impactful on sun protection behaviours. Adolescents did not see the relevance of sun protection in the UK or for their age group.
CONCLUSIONS
CONCLUSIONS
This is the first study to use a Mexameter to measure skin colour in adolescents. Erythema (visible redness) lasts no more than three days and its measurement before and after a six week summer holiday may not yield relevant or meaningful data. A major challenge is that adolescents do not see the relevance of sun protection and SSE.
TRIAL REGISTRATION
BACKGROUND
International Standard Randomised Controlled Trial Number ISRCTN11141528. Date registered 0/2/03/2018; last edited 31/05/2018. Retrospectively registered.
Identifiants
pubmed: 32000743
doi: 10.1186/s12889-020-8265-0
pii: 10.1186/s12889-020-8265-0
pmc: PMC6990594
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
131Subventions
Organisme : Chief Scientist Office
ID : CGA/18/06
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : CGA_18_16
Pays : United Kingdom
Références
Photodermatol Photoimmunol Photomed. 2014 Oct;30(5):266-76
pubmed: 24417381
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
Clin Exp Dermatol. 2015 Jun;40(4):438-40
pubmed: 25683325
Int J Cancer. 2011 Aug 1;129(3):713-23
pubmed: 20857492
BMC Med Res Methodol. 2010 Jul 16;10:67
pubmed: 20637084
Health Educ Res. 2006 Aug;21(4):518-26
pubmed: 16469761
Health Psychol. 1989;8(2):195-219
pubmed: 2737174
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1360-6
pubmed: 16835337
J Community Health Nurs. 2017 Apr-Jun;34(2):80-88
pubmed: 28467204
BMJ Open. 2014 May 02;4(5):e005137
pubmed: 24793258
Prev Med. 2016 Sep;90:121-32
pubmed: 27374946
Br J Health Psychol. 2016 Nov;21(4):733-740
pubmed: 27709824
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):442-53
pubmed: 22329864
Br J Soc Psychol. 2006 Mar;45(Pt 1):87-106
pubmed: 16573874
Br J Dermatol. 2009 Jun;160(6):1292-8
pubmed: 19416235
Br J Health Psychol. 2013 Feb;18(1):182-217
pubmed: 22989352
Prev Med. 1999 Feb;28(2):119-30
pubmed: 10048103
Psychol Bull. 2001 Mar;127(2):267-86
pubmed: 11316014
Skin Res Technol. 2015 Aug;21(3):346-62
pubmed: 25645051
Ann Epidemiol. 2008 Aug;18(8):614-27
pubmed: 18652979
BMC Public Health. 2018 May 29;18(1):666
pubmed: 29843654
Am J Prev Med. 2006 Jan;30(1):13-22
pubmed: 16414419
Br J Dermatol. 2011 Oct;165(4):859-64
pubmed: 21623751
Am J Prev Med. 2004 Dec;27(5):422-66
pubmed: 15556744
BMC Public Health. 2012 Feb 10;12:118
pubmed: 22324969
Aust N Z J Public Health. 2001;25(1):62-5
pubmed: 11297305
Prev Med. 2010 Sep-Oct;51(3-4):325-8
pubmed: 20637795
Health Educ Res. 2008 Oct;23(5):763-9
pubmed: 18039727
BMC Med Res Methodol. 2010 Jan 06;10:1
pubmed: 20053272
Eur J Cancer Prev. 2014 Jul;23(4):303-9
pubmed: 24871562
Am J Prev Med. 2014 Nov;47(5):617-23
pubmed: 25053602
Br J Cancer. 2018 Apr;118(8):1130-1141
pubmed: 29567982
Circulation. 2009 Apr 7;119(13):1694-6
pubmed: 19349331
Prev Med. 2018 Jun;111:442-450
pubmed: 29425724
J Behav Med. 2013 Oct;36(5):508-19
pubmed: 22790653
PLoS Med. 2008 Jul 1;5(7):e141
pubmed: 18597549
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):732-7
pubmed: 25185510
J Public Health Dent. 2011 Winter;71 Suppl 1:S52-63
pubmed: 21656954
J Behav Med. 2016 Dec;39(6):935-946
pubmed: 27515801
Health Educ Res. 2000 Jun;15(3):271-81
pubmed: 10977375
Srp Arh Celok Lek. 2014 May-Jun;142(5-6):330-6
pubmed: 25033590
Health Psychol. 2017 Mar;36(3):215-225
pubmed: 27819460
Photochem Photobiol. 2009 Jan-Feb;85(1):88-98
pubmed: 18657052
Am J Public Health. 2013 Jun;103(6):e38-46
pubmed: 23597377
J Skin Cancer. 2012;2012:629652
pubmed: 23091726
BMC Med Res Methodol. 2016 Oct 6;16(1):132
pubmed: 27716063
Arch Dermatol Res. 2009 Mar;301(3):219-26
pubmed: 18615254
J Am Acad Dermatol. 2001 Mar;44(3):512-9
pubmed: 11209125
Arch Dermatol. 2008 Feb;144(2):217-22
pubmed: 18283179
J Prim Prev. 2018 Aug;39(4):371-386
pubmed: 30008040
Health Educ Behav. 2017 Dec;44(6):937-944
pubmed: 28363246
Psychol Health. 2008;23(1):91-112
pubmed: 25159909
Med J Aust. 1987 Nov 16;147(10):475-6
pubmed: 3683258
Am J Psychiatry. 2013 Apr;170(4):408-13
pubmed: 23318372
Br J Cancer. 2007 Jun 4;96(11):1772-7
pubmed: 17533392
Health Psychol. 1994 Sep;13(5):412-20
pubmed: 7805636
J Public Health (Oxf). 2014 Mar;36(1):140-8
pubmed: 23554510